Abstract Details

Title Pharmacokinetic Evaluations of ADS-4101 (Lacosamide) Modified Release Capsules versus Lacosamide IR in Two Phase 1 Studies up to 600 mg

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) P1 - (-)

Poster/Presentation
Number 263

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Rajiv Patni, MD (Adamas Pharmaceutials) PRESENTER	No disclosure on file
	No disclosure on file
	No disclosure on file
April Ruby	April Ruby has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for ProJenX, Inc.
	No disclosure on file
	No disclosure on file
Jack Nguyen	No disclosure on file

��ɫ��